ureteral stone disease. Presence of urogenital implants
Conditions
Interventions
Intervention 1: Intervention group: Treated with anticholinergics and gabapentin 100 mg orally once daily. Solifenacin 5 mg orally is used as an anticholinergic drug. After 2 weeks from the start of t
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with unilateral ureteral stones more than 15 mm in diameter who have undergone TUL lithotripsy Patients should be over 18 years old A double G catheter is installed for them
Exclusion criteria
Exclusion criteria: Chronic use (more than 3 months) of alpha-blocker and analgesic drugs History of neurogenic bladder Recurrent urinary tract infections Chronic pelvic pain Patient dissatisfaction Leaving the study during the study process People who are contraindicated in gabapentin History of previous allergy to gabapentin Pregnancy Breastfeeding Liver failure Renal failure People who are in the high-risk group due to the drowsiness complication of the drug
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Score obtained based on the patient's irritating symptoms questionnaire. Timepoint: Before intervention and 14 days after gabapentin. Method of measurement: ureteral stent symptom questionnaire (USSQ). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Salman Soltani
Mashhad University of Medical Sciences
Outcome results
None listed